WT1 and acute myeloid leukemia: In the NK-AML subgroup, subjects in the high expression group were older,had higher expression of Wilms tumor gene 1 (WT1) at diagnosis and higher minimal residual disease (MRD) levels after a course of induction chemotherapy (Table 1).